LONG-TERM SAFETY AND EFFICACY CLINICAL-TRIAL WITH RECOMBINANT FACTOR-VIII

被引：0
|
作者：
WHITE, G
GOMPERTS, E
LIUMARUYA, S
机构：
[1] UNIV N CAROLINA,RECOMBINATE COLLABORAT STUDY GRP,CHAPEL HILL,NC 27514
[2] BAXTER HULAND DIV,GLENDALE,CA
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：705 / 705
页数：1
相关论文
共 50 条
  • [31] RELATION OF ACTIVATED FACTOR-VIII TO THE POTENCY IN FACTOR-VIII CONCENTRATES, COMPARISON OF PLASMA-DERIVED AN RECOMBINANT FACTOR-VIII
    MINAMIYAMA, T
    ITO, Y
    OGURI, S
    KOBAYASHI, K
    TAKEDA, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 942 - 942
  • [32] Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a
    Konkle, Barbara
    Pasi, K. John
    Perry, David J.
    Mahlangu, Johnny
    Rangarajan, Savita
    Brown, Simon A.
    Hanabusa, Hideji
    Pabinger, Ingrid
    Cristiano, Lynda M.
    Tsao, Elisa
    Winding, Bent
    Glazebrook, Desilu
    Lethagen, Stefan
    Jackson, Shannon
    BLOOD, 2016, 128 (22)
  • [33] Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study
    Pasi, J.
    Perry, D.
    Mahlangu, J.
    Konkle, B.
    Rangarajan, S.
    Brown, S. A.
    Hanabusa, H.
    Jackson, S.
    Pabinger-Fasching, I.
    Cristiano, L. M.
    Li, X.
    Pierce, G. F.
    Allen, G.
    HAEMOPHILIA, 2015, 21 : 52 - 53
  • [34] Interim Analysis Of The ASPIRE Study Evaluating Long-term Safety And Efficacy Of Recombinant Factor VIII FC (RFVIIIFC) In Children With Severe Haemophilia A
    Nolan, B.
    Young, G.
    Mahlangu, J.
    Liesner, R.
    Pasi, J.
    Cristiano, L. M.
    Li, X.
    Pierce, G. F.
    Allen, G.
    HAEMOPHILIA, 2015, 21 : 58 - 59
  • [35] MANUFACTURING SAFETY AND QUALITY ASSURANCE OF RECOMBINANT FACTOR-VIII (KOGENATE(R))
    NAVEH, D
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1015 - 1015
  • [36] A multicenter, international clinical trial on safety and efficacy of sucrose-formulated recombinant factor VIII for treatment of hemophilia A
    Brackmann, HH
    Abshire, T
    Scharrer, I
    Hoots, K
    Gazengel, C
    Powell, JS
    Gorina, E
    Kellermann, E
    Vosburgh, E
    THROMBOSIS AND HAEMOSTASIS, 1999, : 472 - 472
  • [37] THE PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII - COMMENTS
    MANNUCCI, PM
    SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 36 - 36
  • [38] RECOMBINANT FACTOR-VIII FOR THE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - SAFETY, EFFICACY, AND DEVELOPMENT OF INHIBITORS
    LUSHER, JM
    ARKIN, S
    ABILDGAARD, CF
    SCHWARTZ, RS
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (07): : 453 - 459
  • [39] CHARACTERIZATION OF RECOMBINANT HUMAN FACTOR-VIII
    EATON, DL
    HASS, PE
    RIDDLE, L
    MATHER, J
    WIEBE, M
    GREGORY, T
    VEHAR, GA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (07) : 3285 - 3290
  • [40] RECOMBINANT FACTOR-VIII - OPENING REMARKS
    FUKI, H
    SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 5 - 5
12345